Correction to “From Discovery to Clinical Trial: YCT-529, an Oral NonHormonal Male Contraceptive Targeting the Retinoic Acid Receptor Alpha”

Rui Shi; Md Abdullah Al Noman; Nadja Mannowetz; Narsihmulu Cheryala; Ehfazul Haque; Nadine Taher; Soma Maitra; Tahmina Naqvi; Sanny S.W. Chung; Akash Bakshi; Jon E. Hawkinson; Henry L. S. Wong; Debra J. Wolgemuth; Gunda I. Georg

doi:10.1021/acs.jmedchem.6c00520

Correction to “From Discovery to Clinical Trial: YCT-529, an Oral NonHormonal Male Contraceptive Targeting the Retinoic Acid Receptor Alpha”

Journal of Medicinal Chemistry 2026 Open access

Read full text

Authors: Rui Shi, Md Abdullah Al Noman, Nadja Mannowetz, Narsihmulu Cheryala, Ehfazul Haque, Nadine Taher, Soma Maitra, Tahmina Naqvi, Sanny S.W. Chung, Akash Bakshi, Jon E. Hawkinson, Henry L. S. Wong

+2 more

Debra J. Wolgemuth, Gunda I. Georg

DOI: 10.1021/acs.jmedchem.6c00520

Cited by: 0

Fields of Study & Subjects

Reproductive Health and Contraception Retinoids in leukemia and cellular processes Sperm and Testicular Function

Publication details

Journal / source: Journal of Medicinal Chemistry
Volume: 69
Issue: 5
Pages: 6295–6295
Publication date: 3 March 2026
Language: EN